Chubb Ltd’s Pfizer PFE Stock Holding History

Chubb Ltd’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-421,600	Closed	-$17M	–	7
2019 Q1	$17M	Hold	421,600	–	–	11.41%	4
2018 Q4	$17.5M	Hold	421,600	–	–	12.66%	3
2018 Q3	$17.6M	Hold	421,600	–	–	11.69%	5
2018 Q2	$14.5M	Hold	421,600	–	–	6.1%	10
2018 Q1	$14.2M	Hold	421,600	–	–	6.17%	10
2017 Q4	$14.5M	Hold	421,600	–	–	6.31%	9
2017 Q3	$14.3M	Hold	421,600	–	–	6.23%	10
2017 Q2	$13.4M	Hold	421,600	–	–	5.71%	10
2017 Q1	$13.7M	Hold	421,600	–	–	5.91%	11
2016 Q4	$13M	Hold	421,600	–	–	5.7%	11
2016 Q3	$13.5M	Hold	421,600	–	–	6.14%	10
2016 Q2	$14.1M	Hold	421,600	–	–	6.09%	8
2016 Q1	$11.9M	Buy	+421,600	New	+$12M	3.23%	22

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chubb Ltd's PFE Position: Q2 2019 in Review

Chubb Ltd sold out of Pfizer (PFE) in Q2 2019, closing a stake of 421,600 shares — an estimated $17M sold.

Chubb Ltd first reported a position in PFE in Q1 2016 and held it in 13 quarters. The position peaked at $17.6M in Q3 2018. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

Chubb Ltd reported no remaining Pfizer position as of Q2 2019 after selling out during the quarter.
Chubb Ltd sold 421,600 Pfizer shares in Q2 2019, an estimated $17M.
Chubb Ltd first reported a position in Pfizer in Q1 2016 and held it in 13 quarters.
Chubb Ltd's Pfizer position peaked at $17.6M in Q3 2018.
2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Chubb Ltd's 13F filing for Q2 2019, filed 7 Aug 2019.